Pleural Effusion in Lung Cancer: More Questions than Answers
Pleural Effusion in Lung Cancer: More Questions than Answers
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Lung cancer remains the most common fatal malignancy, despite more aggressive therapies. Few patients will survive 5 years, as up to 80% of the patients will present with advanced-stage disease at diagnosis. Chemotherapy offers little benefit in terms of median survival and disease-free survival in patients with advanced-stage non-small-cell lung c...
Alternative Titles
Full title
Pleural Effusion in Lung Cancer: More Questions than Answers
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1013921899
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1013921899
Other Identifiers
ISSN
0025-7931,1423-0356
E-ISSN
1423-0356
DOI
10.1159/000338169
